Tonix Pharmaceuticals Holding (TNXP) Other Working Capital Changes (2018 - 2026)

Tonix Pharmaceuticals Holding has reported Other Working Capital Changes for 9 years, with the latest figure at $1.5 million in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 1208.21% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $4.4 million, a 309.58% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 187.49% from the prior year.
• Other Working Capital Changes was $1.5 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $278000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $21.7 million in Q1 2017, with the low at -$5.3 million in Q3 2017.
• Average Other Working Capital Changes over 3 years is $3.7 million, with a median of -$2.1 million recorded in 2018.
• The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes plunged 740.99% in 2022, then soared 1208.21% in 2026.
• Over 5 years, Other Working Capital Changes stood at -$589000.0 in 2022, then jumped by 398.98% to $1.8 million in 2023, then plunged by 267.12% to -$2.9 million in 2024, then jumped by 134.05% to $1.0 million in 2025, then surged by 48.2% to $1.5 million in 2026.
• The last three Other Working Capital Changes figures came in at $1.5 million (Q2 2026), $278000.0 (Q1 2026), and $1.0 million (Q4 2025), per Business Quant data.